GRI vs TECH · P/E 0.1, $3.5M cap vs P/E 65, rev $1.22B
GRI Bio Inc. (GRI) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
GRI Bio Inc. (GRI) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
GRI does not have a complete income-statement cache yet.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
GRI currently screens at market cap $3.5M and trailing P/E 0.1. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the GRI and TECH stock pages for the full models.
Not investment advice.